These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The Complex Role of Botulinum Toxin in Enhancing Goal Achievement for Post-Stroke Patients. Săndulescu MI, Cinteză D, Poenaru D, Potcovaru CG, Păunescu H, Coman OA. Toxins (Basel); 2024 Mar 31; 16(4):. PubMed ID: 38668597 [Abstract] [Full Text] [Related]
3. Botulinum Toxin Type A Treatment Combined with Intensive Rehabilitation for Gait Poststroke: A Preliminary Study. Uchiyama Y, Koyama T, Wada Y, Katsutani M, Kodama N, Domen K. J Stroke Cerebrovasc Dis; 2018 Jul 31; 27(7):1975-1986. PubMed ID: 29610039 [Abstract] [Full Text] [Related]
4. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study. Buyukavci R, Akturk S, Ersoy Y. Eur J Phys Rehabil Med; 2018 Oct 31; 54(5):738-744. PubMed ID: 29422486 [Abstract] [Full Text] [Related]
6. Functional outcomes following ultrasound-guided botulinum toxin type A injections to reduce spastic equinovarus in adult post-stroke patients. Aktürk S, Büyükavcı R, Ersoy Y. Toxicon; 2018 May 31; 146():95-98. PubMed ID: 29530514 [Abstract] [Full Text] [Related]
7. Electrical stimulation of antagonist muscles after botulinum toxin type A for post-stroke spastic equinus foot. A randomized single-blind pilot study. Baricich A, Picelli A, Carda S, Smania N, Cisari C, Santamato A, de Sire A, Invernizzi M. Ann Phys Rehabil Med; 2019 Jul 31; 62(4):214-219. PubMed ID: 31228593 [Abstract] [Full Text] [Related]
9. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial. Rosales RL, Kong KH, Goh KJ, Kumthornthip W, Mok VC, Delgado-De Los Santos MM, Chua KS, Abdullah SJ, Zakine B, Maisonobe P, Magis A, Wong KS. Neurorehabil Neural Repair; 2012 Sep 31; 26(7):812-21. PubMed ID: 22371239 [Abstract] [Full Text] [Related]
13. Outcomes of ambulatory rehabilitation programmes following botulinum toxin for spasticity in adults with stroke. Demetrios M, Gorelik A, Louie J, Brand C, Baguley IJ, Khan F. J Rehabil Med; 2014 Sep 31; 46(8):730-7. PubMed ID: 25073939 [Abstract] [Full Text] [Related]
14. Extracorporeal Shock Waves Versus Botulinum Toxin Type A in the Treatment of Poststroke Upper Limb Spasticity: A Randomized Noninferiority Trial. Wu YT, Yu HK, Chen LR, Chang CN, Chen YM, Hu GC. Arch Phys Med Rehabil; 2018 Nov 31; 99(11):2143-2150. PubMed ID: 30392753 [Abstract] [Full Text] [Related]
15. How could robotic training and botolinum toxin be combined in chronic post stroke upper limb spasticity? A pilot study. Pennati GV, Da Re C, Messineo I, Bonaiuti D. Eur J Phys Rehabil Med; 2015 Aug 31; 51(4):381-7. PubMed ID: 25358636 [Abstract] [Full Text] [Related]
16. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population. Pandyan AD, Vuadens P, van Wijck FM, Stark S, Johnson GR, Barnes MP. Clin Rehabil; 2002 Sep 31; 16(6):654-60. PubMed ID: 12392341 [Abstract] [Full Text] [Related]
17. Combined effects of backward treadmill training and botulinum toxin type A therapy on gait and balance in patients with chronic stroke: A pilot, single-blind, randomized controlled trial. Munari D, Serina A, Disarò J, Modenese A, Filippetti M, Gandolfi M, Smania N, Picelli A. NeuroRehabilitation; 2020 Sep 31; 46(4):519-528. PubMed ID: 32508341 [Abstract] [Full Text] [Related]